grant · US

Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed

Food and Drug Administration

Forecast, not yet open. Dates may change.

AT A GLANCE

About this opportunity

Food and Drug Administration lists this grant. Its status is forecast. Check the official listing for details.

Who it’s for

Independent school districts; County governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"; Native American tribal governments (Federally recognized); Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Special district governments; For profit organizations other than small businesses; Small businesses; Public and State controlled institutions of higher education; State governments; Native American tribal organizations (other than Federally recognized tribal governments); City or township governments; Public housing authorities/Indian…

Explore related listings

General information only, not advice. Govlark lists public opportunities that look relevant to the description given; it does not assess eligibility and does not say you qualify. Always read the official listing and guidelines before applying.

Source: US Government work (public domain) · Source: Grants.gov · Report an error